Drug delivery in a tumour cord model: A computational simulation

M. E. Hubbard, M. Jove, P. M. Loadman, R. M. Phillips, C. J. Twelves, S. W. Smye

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in pharmacokinetic parameters affect tumour exposure to the cytotoxic drug doxorubicin. We used the model to describe the radial and axial distribution of drug in the tumour cord as a function of changes in the transport rate across the cell membrane, blood vessel and intercellular permeability, flow rate, and the binding and unbinding ratio of drug within the cancer cells.We explored how changes in these parameters may affect cellular exposure to drug. The model demonstrates the extent to which distance from the supplying vessel influences drug levels and the effect of dosing schedule in relation to saturation of drug-binding sites. It also shows the likely impact on drug distribution of the aberrant vasculature seen within tumours. The model can be adapted for other drugs and extended to include other parameters. The analysis confirms that computational models can play a role in understanding novel cancer therapies to optimize drug administration and delivery.

LanguageEnglish
Article number170014
Number of pages18
JournalRoyal Society Open Science
Volume4
Issue number5
DOIs
Publication statusPublished - 24 May 2017

Fingerprint

Pharmaceutical Preparations
Neoplasms
Tumor Microenvironment
Computer Simulation
Doxorubicin
Blood Vessels
Permeability
Appointments and Schedules
Pharmacokinetics
Binding Sites
Cell Membrane

Cite this

Hubbard, M. E., Jove, M., Loadman, P. M., Phillips, R. M., Twelves, C. J., & Smye, S. W. (2017). Drug delivery in a tumour cord model: A computational simulation. Royal Society Open Science, 4(5), [170014]. https://doi.org/10.1098/rsos.170014
Hubbard, M. E. ; Jove, M. ; Loadman, P. M. ; Phillips, R. M. ; Twelves, C. J. ; Smye, S. W. / Drug delivery in a tumour cord model : A computational simulation. In: Royal Society Open Science. 2017 ; Vol. 4, No. 5.
@article{79f17dc103094dec943f94d3ce645bc7,
title = "Drug delivery in a tumour cord model: A computational simulation",
abstract = "The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in pharmacokinetic parameters affect tumour exposure to the cytotoxic drug doxorubicin. We used the model to describe the radial and axial distribution of drug in the tumour cord as a function of changes in the transport rate across the cell membrane, blood vessel and intercellular permeability, flow rate, and the binding and unbinding ratio of drug within the cancer cells.We explored how changes in these parameters may affect cellular exposure to drug. The model demonstrates the extent to which distance from the supplying vessel influences drug levels and the effect of dosing schedule in relation to saturation of drug-binding sites. It also shows the likely impact on drug distribution of the aberrant vasculature seen within tumours. The model can be adapted for other drugs and extended to include other parameters. The analysis confirms that computational models can play a role in understanding novel cancer therapies to optimize drug administration and delivery.",
keywords = "Computational modelling, Drug delivery, Drug transport and binding, Mathematical modelling, Pharmacokinetic resistance",
author = "Hubbard, {M. E.} and M. Jove and Loadman, {P. M.} and Phillips, {R. M.} and Twelves, {C. J.} and Smye, {S. W.}",
year = "2017",
month = "5",
day = "24",
doi = "10.1098/rsos.170014",
language = "English",
volume = "4",
journal = "Royal Society Open Science",
issn = "2054-5703",
publisher = "The Royal Society",
number = "5",

}

Hubbard, ME, Jove, M, Loadman, PM, Phillips, RM, Twelves, CJ & Smye, SW 2017, 'Drug delivery in a tumour cord model: A computational simulation', Royal Society Open Science, vol. 4, no. 5, 170014. https://doi.org/10.1098/rsos.170014

Drug delivery in a tumour cord model : A computational simulation. / Hubbard, M. E.; Jove, M.; Loadman, P. M.; Phillips, R. M.; Twelves, C. J.; Smye, S. W.

In: Royal Society Open Science, Vol. 4, No. 5, 170014, 24.05.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug delivery in a tumour cord model

T2 - Royal Society Open Science

AU - Hubbard, M. E.

AU - Jove, M.

AU - Loadman, P. M.

AU - Phillips, R. M.

AU - Twelves, C. J.

AU - Smye, S. W.

PY - 2017/5/24

Y1 - 2017/5/24

N2 - The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in pharmacokinetic parameters affect tumour exposure to the cytotoxic drug doxorubicin. We used the model to describe the radial and axial distribution of drug in the tumour cord as a function of changes in the transport rate across the cell membrane, blood vessel and intercellular permeability, flow rate, and the binding and unbinding ratio of drug within the cancer cells.We explored how changes in these parameters may affect cellular exposure to drug. The model demonstrates the extent to which distance from the supplying vessel influences drug levels and the effect of dosing schedule in relation to saturation of drug-binding sites. It also shows the likely impact on drug distribution of the aberrant vasculature seen within tumours. The model can be adapted for other drugs and extended to include other parameters. The analysis confirms that computational models can play a role in understanding novel cancer therapies to optimize drug administration and delivery.

AB - The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in pharmacokinetic parameters affect tumour exposure to the cytotoxic drug doxorubicin. We used the model to describe the radial and axial distribution of drug in the tumour cord as a function of changes in the transport rate across the cell membrane, blood vessel and intercellular permeability, flow rate, and the binding and unbinding ratio of drug within the cancer cells.We explored how changes in these parameters may affect cellular exposure to drug. The model demonstrates the extent to which distance from the supplying vessel influences drug levels and the effect of dosing schedule in relation to saturation of drug-binding sites. It also shows the likely impact on drug distribution of the aberrant vasculature seen within tumours. The model can be adapted for other drugs and extended to include other parameters. The analysis confirms that computational models can play a role in understanding novel cancer therapies to optimize drug administration and delivery.

KW - Computational modelling

KW - Drug delivery

KW - Drug transport and binding

KW - Mathematical modelling

KW - Pharmacokinetic resistance

UR - http://www.scopus.com/inward/record.url?scp=85019757688&partnerID=8YFLogxK

UR - http://rsos.royalsocietypublishing.org/

U2 - 10.1098/rsos.170014

DO - 10.1098/rsos.170014

M3 - Article

VL - 4

JO - Royal Society Open Science

JF - Royal Society Open Science

SN - 2054-5703

IS - 5

M1 - 170014

ER -